Docteur PHILIPPE GOUPILLE
✨ Profil synthétique
IA · 01/05/2026Le Docteur Philippe Goupille est un rhumatologue hospitalier à Tours, avec une production scientifique importante (h-index de 57 et 465 publications). Ses recherches portent principalement sur les maladies auto-immunes et inflammatoires, notamment la polyarthrite rhumatoïde et les spondyloarthropathies. Il a également dirigé des travaux de recherche dans le domaine des sciences de la vie et de la santé.
Expertises présumées
- Polyarthrite rhumatoïde
- Spondyloarthropathies
- Psoriasis
- Thérapies anti-IL-17
- Thérapies anti-TNF
- Biothérapies non anti-TNF
- csDMARDs
Synthèse automatique à partir des sources publiques (HAL, OpenAlex, theses.fr, ClinicalTrials.gov, FAI²R, ANS). Pas une évaluation clinique. Le médecin peut corriger via son compte.
Diplômes
🎓 DES & spécialité ordinale
- Rhumatologie (SM)
📚 CES (Certificat d'Études Spéciales)
- CES Rhumatologie
🎓 Diplômes
- DE Docteur en médecine
Source : Annuaire Santé ANS (FHIR Practitioner.qualification) · Mises à jour quotidiennes.
Direction de thèses
🎓 1 thèse dirigéeSource theses.fr — signal de direction d'équipe / statut PU-PH (à confirmer via le site universitaire).
Activité de recherche & publications
Source : bases de données publiques (OpenAlex, PubMed).
h-index
57
h articles cités ≥ h fois chacun. Un h de 57 = 57 publications avec 57+ citations.
Citations
11 631
Publications
465
i10-index
150
Thématiques principales
- Rheumatoid Arthritis Research and Therapies ×216
- Spondyloarthritis Studies and Treatments ×190
- Psoriasis: Treatment and Pathogenesis ×102
- Autoimmune and Inflammatory Disorders Research ×44
- Spine and Intervertebral Disc Pathology ×37
Affiliations FR : Université de Tours · Centre National de la Recherche Scientifique · Centre Hospitalier Universitaire de Tours
Source : OpenAlex (CC0, OurResearch). Indicateurs académiques agrégés sur 250 M+ d'œuvres.
Bibliographie
Early peripheral psoriatic arthritis: Baseline features of the first 186 patients in the French Nationwide APACHE Cohort
2025ArticleJoint Bone Spine
Risk of cancer in patients with rheumatoid arthritis under tocilizumab: data from the French national registry REGATE
2025ArticleJoint Bone Spine
When generative artificial intelligence answers to Google Trends about spondyloarthritis: what does a French expert panel think about it?
2025ArticleRMD Open : Rheumatic & Musculoskeletal Diseases
A systematic standardized global assessment of chronic inflammatory rheumatism: Benefits and limitations
2025ArticleRevue du Rhumatisme
Unmet needs in axial spondyloarthritis. Proceedings of the French spondyloarthritis taskforce workshop
2024ArticleJoint Bone Spine
Do SMS/e-mail reminders increase influenza vaccination of rheumatoid arthritis patients under anti-TNF: a nested randomized controlled trial in the ART e-cohort
2024ArticleRheumatology
Standardized reporting for systematic global evaluation of axial spondyloarthritis: An evidence-based and consensus-driven initiative
2024ArticleJoint Bone Spine
Towards the Lowest Efficacious Dose: Results From a Multicenter Noninferiority Randomized Open‐Label Controlled Trial Assessing Tocilizumab or Abatacept Injection Spacing in Rheumatoid Arthritis in Remission
2024ArticleArthritis & rheumatology
Source : HAL — archive ouverte CCSD/CNRS (couvre articles, chapitres EMC, communications congrès, thèses).
Livres & ouvrages
- 📕
Le rachis
2008 · 460 p.
avec Frédéric Lecouvet, Pascal Guigui et al.
- 📕
Le mal de dos
2006 · 127 p.
- 📕
Lombalgies et sciatiques
2004 · Wolters Kluwer France · 163 p.
avec Jean-Pierre Valat, Valérie Vedere
- 📕
Articulation temporo-mandibulaire et polyarthrite rhumatoïde
étude prospective chez 30 polyarthrites rhumatoïdes et 30 sujets témoins
1988
Source : Google Books — filtre catégories médicales/santé/sciences.
Localisation des cabinets
Adresses géocodées via la Base Adresse Nationale (api-adresse.data.gouv.fr). Précision indicative.
Lieux de consultation
SERVICE DE SOINS SNCF
41 Rue GRECOURT, 37000 Tours
☎ 0247321484HospitalierCHRU TROUSSEAU - CHAMBRAY
Avenue DE LA REPUBLIQUE, 37170 Chambray-lès-Tours
☎ 0247474747Hospitalier© OpenStreetMap
Tarifs & secteur de conventionnement
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Prendre rendez-vous & contact
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
Vidéos & interventions (1)
Source YouTube · recherche par nom (homonymes possibles).
Articles de presse (7)
Source : Google News (recherche par nom complet — homonymes possibles, vérifier le contenu).
- Spondyl’asso à Joué-lès-Tours : le point sur les recherches en cours - lanouvellerepublique.fr
📰 lanouvellerepublique.fr · 12/03/2025
<a href="https://news.google.com/rss/articles/CBMi5gFBVV95cUxNU2xYRmhiMjZPeXNGRFI3U0IzdUtOVDQxU3Z4X1FCUmhmajlCdTlyOUgxUlQ5OTNiRUR0c3NKSEdyOG9oQUFvc0IwRVhIQzBiUThJS1NiV1hrcDdESlFzWXA5XzFNNk85RzhWemk4eDRSWTlfZ29WOEhtdWt6VEpHc3BzSU5BNGtYYjZFUkxVS0xNQnFLRmY1NkhxNWg4Q2pCZ1RjbC1EODZ6RDJ5TkFFbXMybHY5a1JEZk
- Mal de dos nocturne, raideur matinale... Et si c’était une spondyloarthrite? - Le Figaro Santé
📰 Le Figaro Santé · 25/11/2019
<a href="https://news.google.com/rss/articles/CBMiqAFBVV95cUxQMXpIWGFlbWw5VEtwRmYwQmhHQUh0b0FhdTJ0cmhmdnVzb2dfMFQwWHg0amQzTUU0OU5fYjFFaXlFbHFOVnBxV1hnWlJKTG1MWGpVMWprUVQ1NV9PT2FVd0k2SHFGeHBMdHJ3X0EzeDliZWZZWnNmekdnSVVESEp1S04xTko2ekoyeHZ0UG9KcnowQzNSMlAxN0VLU0JveUo0RExYcmZYVEI?oc=5" target="_blank">
- Surdité: l’implant cochléaire, une solution exceptionnelle encore mal connue - Le Figaro Santé
📰 Le Figaro Santé · 21/11/2019
<a href="https://news.google.com/rss/articles/CBMirAFBVV95cUxPVnNWeHlMY1dmRmJjM2NESmJvZXZqTkgzVXU2cnI5UHJSd0hlZU03WDNmQVFZMFE2MWZZdGhDWjYwODR5Q0xDMWJJMGxxZ0hUNHFvaGFKR21RVW9QTVFfU0h4RTFKY19rTThRYktMWC1uYzNUQkhiUnhTUTE3UGd5MEs1azg5aEJmVTlIbFZMbjZQTzFGM0NONlJ6ckFUbEtlT1BmdEs3NXR5b1B6?oc=5" target="_bl
- Santé : comment les labos se cachent derrière des campagnes de sensibilisation apparemment neutres - Basta Media
📰 Basta Media · 12/12/2018
<a href="https://news.google.com/rss/articles/CBMinAFBVV95cUxORFNOZFJYWllPVmJqcHYxYTdOTGkwbmp1QkowTmlSdWZ0UXZ1RmdQZjF4QTdaR3RGa0ZLR3hKQXJCN1RPSjhlU0pLcHgzSk5GTEtNZVVpSTFfaksyVzdJamgwNzQxdHl5UElNX0pUVWNEM3pMeld5X1JqRHk5M2JiUVZEODdQM0VrclA3WndOVDR5bFFnRHd2Z2ZFbFM?oc=5" target="_blank">Santé : comment
- L’arsenal thérapeutique s’élargit d’un nouvel anti-IL17 - lequotidiendumedecin.fr
📰 lequotidiendumedecin.fr · 26/09/2018
<a href="https://news.google.com/rss/articles/CBMiswFBVV95cUxPTWlSLWZ0elBrbjQtaVZXLW0wblVQZnFWZDJHOUd0eEF5c08tcGctcGhjRkQyTUpWMmNobG1MNHpSOE5JMzg0cGg4NXVUVWR5d1htNFJpOTc3a3hjUUdfT1Q2cnd1d1pPR0NWaE9zclVwXzB6RHFfSThEWjd3QUJPR041Y2hKRlNueEYzczRoV2FtWnd5TTRSN3FqVUZCSXNlSExFSlNCMkN4aENyYkFSUFNIaw?oc=5" t
- Un essai se fait en quatre phases - lanouvellerepublique.fr
📰 lanouvellerepublique.fr · 08/02/2016
<a href="https://news.google.com/rss/articles/CBMijAFBVV95cUxOcWd0OWZwanhUS3J5T2xNbFlfc0lydDZnanZzSWkwa0RVaFBwdW5wZ18wcDRWTmVkSnVVcUF5ZkRLYk9oQVhqc2ZWZkZRZGwwWnhWSWIyOVNuU09kaWNMVUI0cS1uV0VUNmJiQTZfRV85NGl4a1lZTDZWM0podmZHTU5BQjY0N1NlMGtLZg?oc=5" target="_blank">Un essai se fait en quatre phases</a>
- Lion's Club : un chèque pour la recherche - lanouvellerepublique.fr
📰 lanouvellerepublique.fr · 03/11/2014
<a href="https://news.google.com/rss/articles/CBMiiAFBVV95cUxPZzlsM0xQM0VEb1Q0WVMzSEc3NFJQcVZaSHg3Y2FYTzFVNzdkSzJQZzZKM0dWLUV0U2tKNVc3RGQwMEVaVWN6dkxwc21pdllHVDBLMUtqMjU1elRlSzVSUm9EMTNqRmNXdmpKTHVXTXQ5Vi1laUF5S0gtUDNfUXVkLTRBUklmc296?oc=5" target="_blank">Lion's Club : un chèque pour la recherche</
Top publications · les plus citées
- 2Efficacy of tocilizumab in patients with hand osteoarthritis: double blind, randomised, placebo-controlled, multicentre trial
Annals of the rheumatic diseases · 2021
📚 80 citations🎯 RCR 6.20Top 6% NIH🩺 Clinique - 32022 French Society for Rheumatology (SFR) recommendations on the everyday management of patients with spondyloarthritis, including psoriatic arthritis
Joint bone spine · 2022
📚 47 citations🎯 RCR 5.37Top 7% NIH🔓 Open Access
Publications scientifiques (50) — classées par pathologie
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
Transversal27
▼
Transversal27
▼- Reliability of ultrasound assessment of elementary lesions in psoriatic arthritis and development of a reference dactylitis Atlas
Rheumatology (Oxford, England) · 2026 · Journal Article
Jousse-Joulin S, D'agostino MA, Mouterde G, Naredo E, et al.
- Navigating clinical research challenges in spondyloarthritis: Insights from the French Spondyloarthritis Taskforce (FAST)
Joint bone spine · 2026 · Editorial
Felten R, Goupille P, Wendling D, Pham T
- Residual disease in axial spondyloarthritis. Facts and issues
Joint bone spine · 2026 · Journal Article
Wendling D, Goupille P, Verhoeven F, Prati C
📚 1 cit. - Early peripheral psoriatic arthritis: Baseline features of the first 186 patients in the French Nationwide APACHE Cohort
Joint bone spine · 2025 · Journal Article
Claudepierre P, Gaujoux-Viala C, Constantin A, Berenbaum F, et al.
- The changing face of axial spondyloarthritis over the last 25 years
Joint bone spine · 2025 · Journal Article
Wendling D, Goupille P, Felten R, Pham T, et al.
- Unmet needs in axial spondyloarthritis. Proceedings of the French spondyloarthritis taskforce workshop
Joint bone spine · 2024 · Journal Article
Wendling D, Breban M, Costantino F, Lequerré T, et al.
📚 8 cit.🎯 RCR 2.31 - Can we consider a pre-clinical state of axial spondyloarthritis?
Joint bone spine · 2024 · Editorial
Wendling D, Goupille P, Verhoeven F, Prati C
📚 3 cit.🎯 RCR 1.05 - Axial spondyloarthritis and inflammatory bowel disease: Therapeutic implications
Joint bone spine · 2024 · Editorial
Goupille P, Vuitton L, Wendling D
📚 2 cit. - Efficacy of Janus kinase inhibitors in rheumatoid arthritis
Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2023 · Journal Article
Langbour C, Rene J, Goupille P, Carvajal Alegria G
📚 12 cit.🎯 RCR 1.72 - Clinical significance of a self-reported familial occurrence of rheumatoid arthritis among patients with recent-onset arthritis: data from the ESPOIR cohort
Clinical and experimental rheumatology · 2023 · Journal Article
Guellec D, Carvajal-Alegria G, Daïen C, Gossec L, et al.
- Erratum to "2022 French Society for Rheumatology (SFR) recommendations on the everyday management of patients with spondyloarthritis, including psoriatic arthritis" [Joint Bone Spine 2022;89:105344]
Joint bone spine · 2022 · Published Erratum
Wendling D, Hecquet S, Fogel O, Letarouilly JG, et al.
📚 26 cit.🎯 RCR 2.78🔬→🩺 Translationnel - Axial psoriatic arthritis: New entity or clinical form only?
Joint bone spine · 2022 · Editorial
Wendling D, Verhoeven F, Claudepierre P, Goupille P, et al.
📚 5 cit. - Factors associated with drug-free remission at 5-year in early onset axial spondyloarthritis patients: Data from the DESIR cohort
Joint bone spine · 2022 · Journal Article
Ruyssen-Witrand A, Rousseau V, Sommet A, Goupille P, et al.
📚 4 cit.🩺 Clinique - 2022 French Society for Rheumatology (SFR) recommendations on the everyday management of patients with spondyloarthritis, including psoriatic arthritis
Joint bone spine · 2022 · Journal Article
Wendling D, Hecquet S, Fogel O, Letarouilly JG, et al.
📚 47 cit.🎯 RCR 5.37🔬→🩺 Translationnel - Factors associated with remission at 5-year follow-up in recent-onset axial spondyloarthritis: results from the DESIR cohort
Rheumatology (Oxford, England) · 2022 · Journal Article
Pina Vegas L, Sbidian E, Wendling D, Goupille P, et al.
📚 14 cit.🎯 RCR 1.84🔬→🩺 Translationnel - Current favourable 10-year outcome of patients with early rheumatoid arthritis: data from the ESPOIR cohort
Rheumatology (Oxford, England) · 2021 · Journal Article
Combe B, Rincheval N, Berenbaum F, Boumier P, et al.
📚 20 cit.🎯 RCR 1.70🔬→🩺 Translationnel - Poor assessment of bone mineral density after a forearm fracture in women aged 50 years or older: Data from a French health insurance database
Joint bone spine · 2021 · Letter
Cattelain-Lopez E, Chu Miow Lin D, Happe A, Goupille P, et al.
- Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19
JAMA network open · 2021 · Journal Article
Izadi Z, Brenner EJ, Mahil SK, Dand N, et al.
📚 98 cit.🎯 RCR 5.12🔬→🩺 Translationnel - Lymphoma complicating rheumatoid arthritis: results from a French case-control study
RMD open · 2021 · Journal Article
Kedra J, Seror R, Dieudé P, Constantin A, et al.
📚 21 cit.🎯 RCR 1.60🔬→🩺 Translationnel - Features and Outcomes of Microcrystalline Arthritis Treated by Biologics: A Retrospective Study
Rheumatology and therapy · 2021 · Journal Article
Doaré E, Robin F, Racapé H, Le Mélédo G, et al.
📚 5 cit. - Publisher Correction: Rheumatological features of Whipple disease
Scientific reports · 2021 · Published Erratum
Tison A, Preuss P, Leleu C, Robin F, et al.
- Rheumatological features of Whipple disease
Scientific reports · 2021 · Journal Article
Tison A, Preuss P, Leleu C, Robin F, et al.
📚 19 cit.🎯 RCR 1.65🔬→🩺 Translationnel - Practical Management of patients on anti-IL6R therapy: Practical guidelines drawn up by the Club Rhumatismes et Inflammation (CRI)
Joint bone spine · 2021 · Journal Article
Morel J, Tournadre A, Sellam J, Bouhnik Y, et al.
📚 1 cit. - Practical management of patients on anti-IL17 therapy: Practical guidelines drawn up by the Club Rhumatismes et Inflammation (CRI)
Joint bone spine · 2021 · Journal Article
Tournadre A, Sellam J, Morel J, Jullien D, et al.
📚 1 cit. - Prise en charge des patients atteints de maladies rhumatismales pendant la pandémie de COVID-19 : la Société française de rhumatologie répond aux questions fréquentes posées jusqu’en mai 2020
Revue du rhumatisme (Ed. francaise : 1993) · 2021 · Journal Article
Richez C, Flipo RM, Berenbaum F, Cantagrel A, et al.
- Pregnancy rates and outcomes in early axial spondyloarthritis: An analysis of the DESIR cohort
Joint bone spine · 2021 · Journal Article
Pons M, Dougados M, Costedoat-Chalumeau N, Briot K, et al.
📚 9 cit.🔬→🩺 Translationnel - Toward a tailored therapeutic prescription for patients with axial spondyloarthritis
Joint bone spine · 2021 · Editorial
Goupille P, Wendling D
📚 4 cit.🔬→🩺 Translationnel
Anti-IL-176
▼
Anti-IL-176
▼- Initial C-reactive protein level: Discriminating between anti-TNF and anti-IL-17 agents as the first biologic treatment for axial spondyloarthritis?
Joint bone spine · 2024 · Editorial
Goupille P, Wendling D
📚 2 cit. - Impact of the time of initiation and line of biologic therapy on the retention rate of secukinumab in axial spondyloarthritis (axSpA): data from the French multicentre retrospective FORSYA study
RMD open · 2024 · Multicenter Study
Dougados M, Lardy-Cléaud A, Desfleurs E, Claudepierre P, et al.
📚 5 cit.🎯 RCR 1.25🔬→🩺 Translationnel - Enthesitis in patients with psoriatic arthritis treated with secukinumab or adalimumab: a post hoc analysis of the EXCEED study
Rheumatology (Oxford, England) · 2024 · Journal Article
Kaeley GS, Schett G, Conaghan PG, McGonagle D, et al.
📚 8 cit.🎯 RCR 2.13 - Factors associated with the retention of secukinumab in patients with axial spondyloarthritis in real-world practice: results from a retrospective study (FORSYA)
RMD open · 2023 · Journal Article
Dougados M, Lucas J, Desfleurs E, Claudepierre P, et al.
📚 24 cit.🎯 RCR 3.95🔬→🩺 Translationnel - New-onset inflammatory bowel diseases among IL-17 inhibitor-treated patients: results from the case-control MISSIL study
Rheumatology (Oxford, England) · 2022 · Journal Article
Letarouilly JG, Pham T, Pierache A, Acquacalda É, et al.
📚 8 cit.🔬→🩺 Translationnel - Impact of disease activity outcome measures reporting in the medical records of patients with axial spondyloarthritis on the retention rates of biological treatment: the example of secukinumab use in daily practice in France
RMD open · 2022 · Journal Article
Dougados M, Lucas J, Desfleurs E, Lukas C, et al.
📚 6 cit.
Anti-TNF6
▼
Anti-TNF6
▼- Initial C-reactive protein level: Discriminating between anti-TNF and anti-IL-17 agents as the first biologic treatment for axial spondyloarthritis?
Joint bone spine · 2024 · Editorial
Goupille P, Wendling D
📚 2 cit. - Enthesitis in patients with psoriatic arthritis treated with secukinumab or adalimumab: a post hoc analysis of the EXCEED study
Rheumatology (Oxford, England) · 2024 · Journal Article
Kaeley GS, Schett G, Conaghan PG, McGonagle D, et al.
📚 8 cit.🎯 RCR 2.13 - Real-life golimumab persitence in patients with axial spondyloarthritis: post-hoc results of the prospective observational cohort study, GO-PRACTICE
Clinical and experimental rheumatology · 2022 · Journal Article
Goupille P, Bertin P, Tubach F, Lespessailles E, et al.
📚 4 cit.🩺 Clinique - Infliximab Efficacy May Be Linked to Full TNF-α Blockade in Peripheral Compartment-A Double Central-Peripheral Target-Mediated Drug Disposition (TMDD) Model
Pharmaceutics · 2021 · Journal Article
Ternant D, Le Tilly O, Picon L, Moussata D, et al.
📚 7 cit. - PRACTICAL MANAGEMENT of patients on anti-TNF therapy: Practical guidelines drawn up by the Club Rhumatismes et Inflammation (CRI)
Joint bone spine · 2021 · Journal Article
Sellam J, Morel J, Tournadre A, Bouhnik Y, et al.
📚 3 cit.🔬→🩺 Translationnel - Real-life persistence of golimumab in patients with chronic inflammatory rheumatic diseases: results of the 2-year observational GO-PRACTICE study
Clinical and experimental rheumatology · 2021 · Journal Article
Flipo RM, Tubach F, Goupille P, Lespessailles E, et al.
📚 8 cit.🩺 Clinique
Biothérapies non-anti-TNF5
▼
Biothérapies non-anti-TNF5
▼- Risk of cancer in patients with rheumatoid arthritis under tocilizumab: Data from the French national registry REGATE
Joint bone spine · 2025 · Journal Article
Morel J, Wetzman A, Wendling D, Soubrier M, et al.
📚 1 cit. - Two-year treatment persistence with subcutaneous abatacept in rheumatoid arthritis: results from the French cohort of the ASCORE study
Clinical and experimental rheumatology · 2024 · Journal Article
Flipo RM, Constantin A, Goupille P, Chartier M, et al.
🩺 Clinique - Towards the Lowest Efficacious Dose: Results From a Multicenter Noninferiority Randomized Open-Label Controlled Trial Assessing Tocilizumab or Abatacept Injection Spacing in Rheumatoid Arthritis in Remission
Arthritis & rheumatology (Hoboken, N.J.) · 2024 · Randomized Controlled Trial
Kedra J, Dieudé P, Giboin C, Marotte H, et al.
📚 3 cit.🩺 Clinique - Stable efficacy and safety after switching from intravenous to subcutaneous tocilizumab in a cohort of 200 patients in real life conditions
Joint bone spine · 2022 · Letter
Larid G, Joffres L, Ricard E, Pereira Gillion C, et al.
📚 2 cit. - Efficacy of tocilizumab in patients with hand osteoarthritis: double blind, randomised, placebo-controlled, multicentre trial
Annals of the rheumatic diseases · 2021 · Journal Article
Richette P, Latourte A, Sellam J, Wendling D, et al.
📚 80 cit.🎯 RCR 6.20🩺 Clinique
IA en rhumatologie2
▼
IA en rhumatologie2
▼- When generative artificial intelligence answers to Google Trends about spondyloarthritis: what does a French expert panel think about it?
RMD open · 2025 · Letter
Verhoeven F, Fakih O, Miceli-Richard C, Pham T, et al.
- Machine learning reveals the most important psychological and social variables predicting the differential diagnosis of rheumatic and musculoskeletal diseases
Rheumatology international · 2022 · Journal Article
Vera Cruz G, Bucourt E, Réveillère C, Martaillé V, et al.
📚 20 cit.🎯 RCR 2.59
Spondyloarthrite2
▼
Spondyloarthrite2
▼- Impact of the time of initiation and line of biologic therapy on the retention rate of secukinumab in axial spondyloarthritis (axSpA): data from the French multicentre retrospective FORSYA study
RMD open · 2024 · Multicenter Study
Dougados M, Lardy-Cléaud A, Desfleurs E, Claudepierre P, et al.
📚 5 cit.🎯 RCR 1.25🔬→🩺 Translationnel - Enthesitis in patients with psoriatic arthritis treated with secukinumab or adalimumab: a post hoc analysis of the EXCEED study
Rheumatology (Oxford, England) · 2024 · Journal Article
Kaeley GS, Schett G, Conaghan PG, McGonagle D, et al.
📚 8 cit.🎯 RCR 2.13
csDMARDs1
▼
csDMARDs1
▼- Treatment with Targeted Therapy in Patients with Psoriatic Arthritis and Inadequate Response to Methotrexate: Proposal for a Rational Strategy
Rheumatology and therapy · 2024 · Journal Article
Goupille P, Carvajal Alegria G, Verhoeven F, Wendling D
📚 3 cit.
Épidémiologie & registres1
▼
Épidémiologie & registres1
▼- High prevalence of clinical and biological features of metabolic syndrome in patients with epidural lipomatosis: A single-center, retrospective study
Joint bone spine · 2022 · Letter
Doize H, Bodet-Contentin L, Dhalluin T, Maillot F, et al.
📚 1 cit.
Essai clinique1
▼
Essai clinique1
▼- Predictors of response to TNF inhibitors in rheumatoid arthritis: an individual patient data pooled analysis of randomised controlled trials
RMD open · 2021 · Journal Article
Law-Wan J, Sparfel MA, Derolez S, Azzopardi N, et al.
📚 15 cit.🎯 RCR 1.20🔬→🩺 Translationnel
JAK inhibiteurs1
▼
JAK inhibiteurs1
▼- Safety Profile of Upadacitinib up to 3 Years in Psoriatic Arthritis: An Integrated Analysis of Two Pivotal Phase 3 Trials
Rheumatology and therapy · 2022 · Journal Article
Burmester GR, Winthrop K, Blanco R, Nash P, et al.
📚 33 cit.🎯 RCR 3.27🔬→🩺 Translationnel
Recommandations1
▼
Recommandations1
▼- Standardized reporting for systematic global evaluation of axial spondyloarthritis: An evidence-based and consensus-driven initiative
Joint bone spine · 2024 · Consensus Statement
Ruyssen-Witrand A, Caillet-Portillo D, Najm A, Fogel O, et al.
📚 1 cit.
Stratégie thérapeutique1
▼
Stratégie thérapeutique1
▼- Tight control and treat-to-target in axial spondyloarthritis. Where are we?
Joint bone spine · 2022 · Editorial
Wendling D, Claudepierre P, Goupille P, Pham T, et al.
📚 7 cit.🔬→🩺 Translationnel
Datasets & protocoles partagés
44èmes journées FMC - comment traiter et suivre les spondylarthrites?
Audiovisual2007Canal-U/MédecinePhilippe Goupille nous explique comment traiter et suivre les spondylarthrites. Origine 44èmes journées FMC - Tours Canal-U Médecine et Santé Générique Réalisati
Anti-CCP2 concentrations at baseline (month 0 (M0)), 1 year (M12) and 3 years (M36) of follow-up according to decreasing concentrations (panel 1 and 2), increasing concentrations (panel 1 and 2) or steady concentrations
Image2011figshare<b>Copyright information:</b>Taken from "Serial determination of cyclic citrullinated peptide autoantibodies predicted five-year radiological outcomes in a prospective cohort of patients with early rheumatoid arthritis"A
Anti-CCP2 concentrations at baseline (month 0 (M0)), 1 year (M12) and 3 years (M36) of follow-up according to decreasing concentrations (panel 1 and 2), increasing concentrations (panel 1 and 2) or steady concentrations
Image2011figshare<b>Copyright information:</b>Taken from "Serial determination of cyclic citrullinated peptide autoantibodies predicted five-year radiological outcomes in a prospective cohort of patients with early rheumatoid arthritis"A
Features and Outcomes Of Microcrystalline Arthritis Treated by Biologics: A Retrospective Study
Audiovisual2021Adis Journals<strong>Article full text</strong> <br> The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online
Features and Outcomes Of Microcrystalline Arthritis Treated by Biologics: A Retrospective Study
Audiovisual2021Adis Journals<strong>Article full text</strong> <br> The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online
Source : DataCite — DOIs pour datasets, logiciels, protocoles, registres patient. Hors articles (déjà couverts).

